Skip to content

Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version in Taiwan

Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version of the EORTC QLQ-PAN26 and EORTC QLQ-C30 in Taiwan

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05147168
Enrollment
300
Registered
2021-12-07
Start date
2021-11-22
Completion date
2024-11-22
Last updated
2023-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Keywords

Quality of life, Psychometric Validation

Brief summary

This study will investigate the reliability and validity of Chinese version of the quality of life scale in EORTC QLQ-PAN26 and EORTC QLQ-C30 on pancreatic cancer patients in Taiwan

Detailed description

1. Verify the reliability and validity of Chinese version of the EORTC QLQ-C30 Quality of Life Scale and the chinese version of the EORTC QLQ-PAN26 Quality of Life Scale. 2. Verify the construct validity of the Chinese version of the EORTC QLQ-PAN26 Quality of Life Scale, perform factor analysis, test-retest reliability, and known group validity 3. Verify the criterion related validity of Chinese version of the EORTC QLQ-C30 Quality of Life Scale and the SF-36 Quality of Life Scale

Interventions

OTHERQuestionnaire

Psychometric Validation of Chinese Version of the EORTC QLQ-PAN26 and EORTC QLQ-C30 in Taiwan

Sponsors

Taipei Veterans General Hospital, Taiwan
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Paitent who aged over 20, with clear consciousness, is capable of communicating with Chinese. 2. Pancreatic Cancer patients(stage I.II.III.IV) 3. The subject who agrees and is willing to participate in the research after explaining the purpose of the research.

Exclusion criteria

1\. Patient who is younger than 20 years old, illiterate, or is unable to cooperate with intervention measures.

Design outcomes

Primary

MeasureTime frameDescription
Quality of Life (EORTC QLQ-C30 )baselineThis scale was evaluated by self-assessment of various clinical problems for a week.The EORTC QLQ-C30 consists three subscales with 30 questions.The EORTC QLQ-C30 included three subscales: functioning scales (15questions), symptom scales (13 questions), and global health status (2questions). The reliability and validity of Cronbach'α was 0.52-0.89. About the functional scale and the global health status, the higher the total score, the better the quality of life; the lower the score in the symptom scale, the better the quality of life.
Quality of Life (EORTC QLQ-PAN26 )baselineThis scale was evaluated by self-assessment of various clinical problems for a week.The EORTC QLQ-PAN26 consists of two subscales with 26 questions.The EORTC QLQ-PAN26 included two subscales:functioning scales (4 questions),symptom scales (22 questions). The reliability and validity of Cronbach'α was 0.69-0.97. About the functional scale, the higher the total score, the better the quality of life; the lower the score in the symptom scale, the better the quality of life.
Quality of Life(SF-36)baselineThis scale was evaluated by self-assessment of various clinical problems for a month.The SF-36 included eight subscales.The reliability and validity of Cronbach'α was 0.57.

Countries

Taiwan

Contacts

Primary ContactWei-Ling Gao, BSN
wlgao@vghtpe.gov.tw886-932637095
Backup ContactHui-Mei Chen, PhD
alice@ntunhs.edu.tw886-2-28227101#3139

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026